Mesenchymal stem cell therapy

1 marketed 2 in Phase 3

This page covers all Mesenchymal stem cell therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (1)

MC · Aivita Biomedical, Inc. · Regenerative Medicine / Tissue Repair
MC is a mesenchymal stem cell (MSC) therapy that promotes tissue repair and regeneration through immunomodulation and paracrine signaling.

Phase 3 pipeline (2)

Standard of Care for GVHD · Mesoblast, Inc. · Immunology
Rexlemestrocel-L is a mesenchymal stem cell therapy that modulates the immune system to treat graft-versus-host disease.
ADSTEM Inj. · EHL Bio Co., Ltd. · Regenerative Medicine / Orthopedics
ADSTEM is an allogeneic adipose-derived mesenchymal stem cell therapy that promotes tissue regeneration and modulates immune responses.